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Angiotensin-converting enzyme inhibitors are the most
efficient pharmacologic agents to delay the development of
end-stage renal disease (ESRD). This is a multipharmacologic
approach that inhibits angiotensin II formation while
increasing kinin concentrations. Considerable attention has
been focused on the role of decreased angiotensin II levels;
however, the role of increased kinin levels is gaining in
interest. Kinins affect cellular physiology by interacting with
one of two receptors being the more inducible B1 and the
more constitutive B2 receptors. This study utilizes the mouse
remnant kidney of 20 weeks duration as a model of ESRD.
Whole mouse genome microarrays were used to evaluate
gene expression in the remnant kidneys of wild type, B1 and
B2 receptor knockout animals. The microarray data indicate
that gene families involved in vascular damage,
inflammation, fibrosis, and proteinuria were upregulated,
whereas gene families involved in cell growth, metabolism,
lipid, and protein biosynthesis were downregulated in the
remnant kidneys. Interestingly, the microarray analyses
coupled to histological evaluations are suggestive of a
possible protective role of kinins operating through the B2
receptor subtype in this model of renal disease. The results
highlight the potential of microarray technology for
unraveling complex mechanisms contributing to chronic
renal failure.
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The prevalence and incidence of end-stage renal disease
(ESRD) has dramatically increased over the last decade.1
Regardless of the underlying etiology, chronic renal insuffi-
ciency is accompanied by a permanent loss of functional
nephrons leading to a progressive loss of renal function.1 The
remnant kidney model (subtotal or 5/6 nephrectomy (SNX))
is an experimental animal model of chronic renal disease
progression in which the development of segmental glomer-
ulosclerosis and tubulointerstitial fibrosis are both clearly
established after 20 weeks following SNX.2
It is now well admitted that angiotensin-converting
enzyme inhibitors (ACEi) are the most efficient drugs to
delay ESRD development.3 ACE inhibition decreases angio-
tensin II (vasoconstrictor peptide) and increases kinin
(vasodilator peptides) concentrations.4 The beneficial effects
of ACE inhibitors have been well determined; kinin
implications are less clear, although in several studies a role
for kinins was proposed.5,6 Kinins execute their physiological
function through the activation of two types of kinin
receptors, the B1 (B1R) which is overexpressed in pathological
states and the B2 (B2R) which is constitutively expressed.
7
A number of reports have shown involvement of kinin
receptors, as components of the renal kallikrein–kinin system,
in disease states that lead to renal failure (reviewed in Leeb-
Lundberg et al.8). We have recently demonstrated that a
number of genes relevant to renal physiology/pathology were
differentially expressed in B1R-knockout (B1R-KO) and B2R-
knockout (B2R-KO) mice, which is indicative for the
important role of both kinin receptors in renal function.9
To date, kidney disease-oriented research has focused on
mechanisms responsible for ESRD initiation and progression.
However, because ESRD is a complex disease, interruption of
a single pathway is unlikely to result in significant therapeutic
benefit. Further understanding of the pathogenesis of renal
failure and the development of new therapies will thus
require global expression analysis of disease states using
genomics and/or proteomics tools.
In this study, we examined changes of gene expression in
20-week remnant kidneys of SNX wild-type (SNX-WT) mice,
SNX-B1R-KO mice, and SNX-B2R-KO mice to comprehend
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molecular mechanisms of advanced renal disease better and
possible implications of kinin receptors in renal failure.
Numerous genes that encode proteins previously implicated
in ESRD displayed drastic altered expression in 20-week
remnant WT kidneys. However, and importantly, we
observed strong variations in a number of genes and gene
families (cytochrome P450 (CYPs), major urinary proteins
(MUPs), serpins, glutathione S-transferase (GSTs), and
enzymes of the urea cycle) and a novel pathway (linked with
hepatocyte nuclear factor 4-alpha (Hnf4a) signaling) not
previously linked with renal disease progression. The altered
expression of some of these genes is also associated with
possible protective and compensatory mechanisms. Addi-
tionally, our results are indicative for implications of kinin
receptors, and especially the kinin B2R subtype, in chronic
renal disease.
RESULTS
Blood pressure measurements and biochemical analyses
As expected with mice on a C57BL6 genetic background, we
found that our WT- and KO-SNX mice are rather resistant to
glomerulosclerosis, proteinuria, and hypertension.2,10 Indeed
all animals survived 20 weeks of SNX. Consistent with
previously described data,11,12 no significant change in blood
pressure was observed along the study period in the SNX-WT
and SNX-KO animals (Figure 1a). However, the biochemical
analyses performed on urine and blood samples collected
before killing of all SNX mice were confirmative for ESRD
progression (Figure 1b). Serum creatinine was significantly
increased and urinary creatinine was significantly decreased
in SNX animals compared with control animals. Proteinuria
was not significantly different between WT and SNX animals,
but a tendency was observed. No significant difference was
observed in the biochemical parameters between SNX-WT
and SNX-KO animals (Figure 1b).
Gene expression profiling in 20-week WT remnant kidneys
Initially, we identified global changes of renal gene expression
in WT remnant kidneys (20-week post-SNX). The microarray
experiments were performed in triplicates, as the renal gene
expression was compared at random between three separate
pairs of SNX-WT versus WT-sham-operated (WT-C)
animals (SNX-WT/WT-C). A subset of 1131 differentially
expressed genes was selected from all triplicate microarray
data by filtering on expression level (X2-fold). Using these
selection criteria, we found 543 genes to be upregulated and
588 genes to be downregulated in the 20-week remnant
kidneys, compared to that of the control kidneys. Table 1A
shows list of selected functional groups of genes that were
upregulated (X2-fold) in the 20-week remnant kidneys. As
seen from Table 1A, there is substantial number of
upregulated genes with previously shown implication in
mechanisms of renal pathology, including altered lipid
metabolism, inflammation, fibrosis, vascular homeostasis,
and/or reactive oxygen species formation. Some of them
displayed very strong upregulation (45-fold) in remnant
kidneys (indicated in bold). These included albumin (Alb),
fatty acid-binding protein 1 (Fabp1), retinol-binding protein
4 (Rbp4), carbamoylphosphate synthetase 1 (Cps1), apolipo-
proteins Apoa1, Apoa2, Apoh, and Apoc4, kininogen (Kng1),
vitronectin (Vtn), fetuin-A (Ahsg), esterase 1 (Es1), para-
oxonase 1 (Pon1), fibrinogen (Fg), orosomucoid 1 (Orm1),
hemopexin (Hpxn), and different members of the cyto-
chrome P450 gene family (Cyp2c39, Cyp2c40, Cyp3a44,
Cyp2a12, Cyp2c29, Cyp3a11, and Cyp2c40). Interestingly,
four members of the major urinary protein family (Mup1,
Mup3, Mup4, and Mup5) displayed similar high range (45-
fold) of gene expression. Table S1 shows the complete list of
upregulated genes (X2-fold) in the 20-week remnant WT
kidneys.
Five hundred and eighty-eight genes were subject to at
least twofold downregulation in the remnant WT kidneys (a
list of selected downregulated genes is presented in Table 1B).
Among the genes with known functions, major classifications
comprised metabolism (35%), transport (17%), cell growth
and maintenance (11%), transcription (11%), signal trans-
duction (10%), protein turnover (8%), immune response
(4%), apoptosis (2%), proteolysis and peptidolysis (2%), and
more than half (323 genes) had unknown function. Table S2
displays the complete list of the 588 downregulated genes
(p2-fold) in the 20-week remnant WT kidneys.
A network analysis based on the 1131 gene list with
twofold altered expression identified 26 highly significant
networks with score X11 (see Table S3). The four top-
scoring networks are shown in Table 2 and were associated
with the functions of cell-to-cell signaling and interaction,
cellular growth and proliferation, lipid metabolism, mole-
cular transport, and immune response. A common network
obtained upon merging the four top-scoring networks
(Figure 2) recognized several important nodes linked with
numerous interaction partners, including the v-fos FBJ
murine osteosarcoma viral oncogene homolog (Fos), throm-
bin (Thr), fibronectin 1 (Fn1), C-reactive protein (Crp),
plasminogen (Plg), insulin-like growth factor 1 (Igf1), and
Hnf4a. As the majority of these genes and related pathways
were previously associated with renal pathology, the Hnf4a
signaling represents a novel pathway (see also Figure 3),
possibly linked with the mechanisms of advanced renal
disease.
Kinin receptors ablation results in consistent patterns of
altered gene expression in 20-week remnant kidneys
In parallel, we studied global gene expression changes in
20-week remnant kidneys of SNX-B1R-KO and SNX-B2R-KO
mice. Gene expression analyses were performed at random in
five separate pairs (biological replicates) of SNX-B1R-KO
mice versus SNX-WT mice (SNX-B1R-KO/SNX-WT) and six
biological replicates of SNX-B2R-KO versus SNX-WT animals
(SNX-B2R-KO/SNX-WT). A subset of differentially expressed
genes was selected displaying at least twofold difference in
four of the five B1R-KO microarray experiments and in four
of the six B2R-KO microarray experiments. Using these
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Figure 1 | BP measurements and biochemical parameters of ESRD progression in SNX-WT, SNX-B1R-KO, and SNX-B2R-KO mice
20 weeks after SNX. (a) BP measurements; (b) biochemical parameters. Serum creatinine increases (*Po0.0001) and urinary creatinine
decreases (*Po0.001) 20 weeks after SNX in the different animals groups, versus respective controls; n¼ 4–6 mice/group. A tendency of
increased proteinuria was observed in SNX animals but it did not reach statistical significance.
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selection criteria, we found 73 genes to be upregulated and
118 genes to be downregulated in B1R-KO remnant kidneys,
compared with that of WT remnant kidneys, whereas 71
genes were upregulated and 52 genes were downregulated in
B2R-KO remnant kidneys, when compared with WT remnant
kidneys (Tables S4 and S5).
Interestingly, a substantial number of genes (43 upregu-
lated and 30 downregulated) were commonly differentially
expressed in the SNX-B1R-KO/SNX-WT experiments
and in the SNX-WT/WT-C experiments (Figure 4a). In
contrast, the number of the differentially expressed genes
that are common in the SNX-B2R-KO/SNX-WT experiments
and in the SNX-WT/WT-C experiments was considerably
lower (18 upregulated and 0 downregulated genes – see
Figure 4b). The number of overlapping genes in both
experimental conditions including kinin receptors KO
Table 1 | Selected functionally related groups of differentially expressed genes (X2-fold)a in 20-week remnant WT kidneys
(A) Upregulated genes
Cytochrome P450 family (vascular
homeostasis and/or ROS formation)
Cyp1a2, Cyp2a12, Cyp2b9, Cyp2b10, Cyp2b13, Cyp2c29, Cyp2c37, Cyp2c38, Cyp2c39, Cyp2c40, Cyp2c54,
Cyp2c70, Cyp2f2, Cyp3a11, Cyp3a16, Cyp3a25, Cyp3a44, Cyp4a14
Lipid metabolism and transport Apoa1, Apoa2, Apoa5, Apoc1, Apoc3, Apoc4, Apoe, Apof, Apoh, Fabp1, Sult2a2, Sth2a1, Slc27a5, Pon1,
Sth2, Acdc
Serpins; proteolysis and peptidolysis Serpina1b, Serpina1d, Serpina1e, Serpina3c, Serpina3k, Serpina3n, Serpina6, Serpina10, Serpinc1,
Serping1, F2, F10
Solute carriers and other transporters Slc7a12, Slc10a1, Slc38a4, Slco1b2, Car3, Slc16a4, Slc26a8, Slc39a4, Ambp
Inflammation; complement activation Es1, C4bp, Orm1, Hpxn, Es31, C3, Hamp, Orm2, Hp, Cfh, Saa4, Cpb2, Cfi, Cfhl1, Adn, Mbl2, Retn, Plg, Hpgd,
C1r, C9, C1s, Masp, Crp
Immune response H2-Bl, Ig-c1, Was, Igh-VJ558, Igl-6G14-F6, H2-Q10, Cd1d1, Igj, Igl-11, C6-E3, Ig-j V-V, Wasf3, Igg1,
Igh-L2pecB, Mug2
Fibrosis Fgg, Fgb, Fga, Fgl1, Ppp1r9a, Fgfr1, Fn1
Apoptosis Card14, Csnk2a1, Il21r, Clu
ECM proteins Csf3r, Vtn, Lum, Ceacam2
Cell growth and proliferation Igf2, Rgn, Igf1b, Igf1, Hel308
Oxidative stress (pro- and antioxidants) Maob, Uox, Hao3, Cp, Hao1, Trf, Trfr2, Ucp1, Gsta3, Gsta2, Gsta1, Akr1c20, Akr1c6, Akr1c12, Cbr1
Enzymes of the urea cycle Cps1, Arg1, Arg2, Otc
Major urinary proteins Mup1, Mup3, Mup4, Mup5
Other genes relevant to renal pathology Alb1, Ahsg, Rbp4, Kng1, Agxt
(B) Downregulated genes
Cell growth and metabolism Fgf5, Fgf2, Odc, Odc1, Tph1, Dhrs8, Dhrs1, Ldhd, Ldh1, Atp11a, Mod1, B4galt5, Psap, Sah, Slc27a2, Ugt8,
Pcyt1a, Crot, Cyb5, Tgfbr2, Acox1, Acox3, Mapk6
Transport Cacna2d2, Uty, Pitpnm1, Kcnk5, Slco1a1, Slco1a5, Slc7a13, Slco1a1, Tnpo3
Protein biosynthesis Eif2s3y, Eif5a, Polr3e, Gfm, AK018591, Mrpl12
Cell adhesion Pcdhb9, Pcdh8, Itga2b, Lama1, Dscaml1, Gjc1, Mmp5
Cytochrome P450 family Cyp2j13, Cyp4b1, Cyp7b1
Apoptosis Bcl2I1, Cideb, Dnase1, Pdcd8
Genes relevant to renal pathology Hba-a, Hb-b, Hb-b-b1, Pkd2, Nppb, AceI
ECM, extracellular matrix; ROS, reactive oxygen species.
aGenes in bold are differentially expressed at least X5-fold in all microarray experiments.
Table 2 | The four top-scoring genetic networks in the 20-week remnant WT mouse kidneys
Network Genes in ingenuity networksa Scoreb Functions
1 mANG, mAPOH, CDCP1, mCEACAM1, mCISH, mCP, mCPB2, kCSDA, mCSF3R, mDCN, mDF,
mF10, mFABP4, kFOXE1, mIGF1, mIGF2, kIGFBP3, kINS, mLYZ, kMMP2, mPLG, mPRLR,
kPTHR1, mRARRES2, mSERPINA3, mSERPINA10, mSERPINC1, kSERPINF2, kSLC20A1,
mSOCS2, mTF, mTFPI, mTFR2, mVTN, kZFP35
46 Cell-to-cell signaling and
interaction, cellular growth,
and proliferation
2 mAPOA1, mAPOA2, mAPOC1, mAPOC3, mAPOE, kBLMH, mC9, mC4A, mC8G, mCLU,
mCUGBP2, kENO1, kFARS2, mFGA, mFGB, mFOS, mGCNT1, kHNF4A, mHPD, mLCAT,
kLDHA, kNP, kOAZ1, kOCM, kODC1, mPON1, mPRKAR2B, mPYGL, kRNH, kRPS6KA3,
kSLC27A2, kSMARCD1, kSPN, mTDO2, kTEGT
46 Lipid metabolism, molecular
transport, small molecule
biochemistry
3 mABCC3, kACE, mALB, mC3, mC1R, kCD9, kCD63, mCFH, kCYBA, mCYP2B2, mDGKQ, mF2,
kFGF2, mGLUL, mGPNMB, mIF, mITGA6, kITGA2B, mKNG1, mMAFB, mMASP1, mMASP2,
mMBL2, kMEP1B, kNAGK, kNOX3, kPBP, kPIK4CA, kPITPNM1, mPRKCB1, mSCD,
kSERPINA5, mSERPING1, kSMPD2, kTNS
46 Cardiovascular disease, tissue
morphology, lipid metabolism
4 kACOX1, mADIPOQ, mAPOA5, kATP6V0C, mB2M, mCANX, mCD1D, kCPT1A, mCRP,
mCSNK2A1, mCXCL9, mDCT, mFASN, mFCER1G, mFN1, mHLA-A, mHLA-B, mHLA-E, mIGHG1,
mIGHM, mIL2, kIL2RA, mKLRC2, mLOC56628, kLPL, mMUG1, kMYH1, kNPPB, kPDCD8,
mPTPN6, mSERPINA1, kSNRPN, kU2AF2, mUCP1, kZBTB7
46 Cell-to-cell signaling and
interaction, immune response
aUpregulated (m) and downregulated (k) genes are indicated with arrows.
bA score 43 was considered significant.
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mice was also negligible (Figure 4c). However, some
functionally important renal pathology genes, including
genes implicated in renal fibrosis (Fga, Fgg, Saa2, Edn1,
and Ren1) were uniquely overexpressed only in the B2R-KO
remnant kidneys. This also holds for a subset of genes,
functionally implicated in control of cell proliferation (Nrg3,
Sycp3, Plec1, Ptn, Kif11, and Kif13a), found to be exclusively
downregulated in remnant kidneys of the B2R-KO mice
(Table S5).
Table 3 displays the classifications by function of the
differentially expressed genes in both experimental condi-
tions involving kinin receptors-KO mice (SNX-B1R-KO/
SNX-WT and SNX-B2R-KO/SNX-WT). These data are
indicative for some similarities, as well for some differences
in the functional classes that are specific for each mouse KO
strain. Thus among the upregulated genes, major classifica-
tions in the B1R-KO remnant kidneys include transport,
metabolism (especially lipid transport and metabolism),
Figure 2 | Network analysis of dynamic gene expression in the 20-week remnant kidneys based on the twofold gene expression list.
The top four networks were merged and are displayed graphically as nodes (genes/gene products) and edges (the biological relationships
between the nodes). Intensity of the node color indicates the degree of upregulated (red) or downregulation (green). Nodes are displayed
using various shapes that represent the functional class of the gene product (square, cytokine; vertical oval, transmembrane receptor;
rectangle, nuclear receptor; diamond, enzyme; rhomboid, transporter; hexagon, translation factor; horizontal oval, transcription factor; and
circle, other). Edges are displayed with various labels that describe the nature of the relationship between the nodes: — binding only;- acts
on. The length of an edge reflects the evidence supporting that node-to-node relationship, in that edges supported by more articles from the
literature are shorter. Dotted edges represent indirect interaction.
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proteolysis and peptidolysis, whereas in B2R-KO remnant
kidneys, the top functional classes are associated with
metabolism, signal transduction, transport, and acute-phase
response (Table 3A). As for the downregulated genes,
functional groups in the B1R-KO remnant kidneys mostly
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Figure 3 | The Hnf4a signaling pathway. Figure legends are as described in Figure 2. Edge labels: A, activation; B, binding; E, expression; PP,
protein–protein binding; RB, regulation of binding; LO, localization.
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Figure 4 | Comparisons of the common and distinct gene
expression across the different experimental conditions using
the Venn diagram analysis. (a) Comparison for upregulated genes.
(b) Comparison for downregulated genes. (c) The different
experimental conditions subject to comparison are indicated
(see details in text).
Table 3 | Functional distribution of the differentially
expressed genes (twofold) in remnant kidneys of SNX kinin
receptors KO mice compared with SNX-WT mice
SNX-B1R-KO: functional groups %
SNX-B2R-KO:
functional groups %
(A) Upregulated genes (X2-fold)
Transport 21.9 Metabolism 15.3
Metabolism 17.2 Signal transduction 12.5
Proteolysis and peptidolysis 14.1 Transport 12.5
Lipid metabolism and transport 10.9 Acute phase
response
9.7
Immune response 9.4 Transcription 8.3
Inflammation 7.8 Inflammation 5.6
Other 6.2 Immune response 5.5
Unknown function 12.5 Vasoconstriction 2.8
Unknown function 27.8
(B) Downregulated genes (p2-fold)
Metabolism 12.4 Signal transduction 17.3
Transcription 8.3 Transcription 13.5
Signal transduction 6.6 Cell proliferation 11.5
Cell growth and proliferation 5.8 Transport 11.5
Transport 5.8 Metabolism 7.7
Immune response 4.9 Immune response 5.8
Apoptosis 3.3 Unknown function 32.7
Unknown function 52.9
KO, knockout; SNX, subtotal or 5/6 nephrectomy; WT, wild type.
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comprise metabolism, transcription, and signal transduction,
whereas in the B2R-KO remnant kidneys these mainly include
signal transduction, transcription, cell proliferation, and
transport (Table 3B). The differences between the two
SNX-KO strains were further confirmed by clustering and
pathway analysis. Supervised clustering based on a selected
list of 65 genes revealed formation of two major cluster
groups that perfectly distinguish between SNX-B1R-KO and
SNX-B2R-KO kidney samples (Figure 5). The 65 gene list is
presented in Table S6. Twenty genes from the 65 genes list
were upregulated in the B2R-KO remnant kidneys. Major
classifications of these genes include metabolism and
regulation of transcription. Genes, upregulated in B1R-KO
remnant kidneys (45 genes) are mainly involved in signal
transduction, metabolism, transport, and apoptosis.
Network analysis identified three significant gene networks
in both up and down-differentially expressed genes in the
B1R-KO remnant kidneys, whereas in the B2R-KO remnant
kidneys three networks for the upregulated genes and two
networks for the downregulated genes displayed a significant
score (Table 4). The discrepancies were mostly evident in the
networks obtained with downregulated genes, as the SNX-
B1R-KO networks were associated with gene expression and
cellular growth and proliferation (Table 4B), whereas the
SNX-B2R-KO networks were mainly linked to immune
response, lipid metabolism, and transport (Table 4D).
Validation of microarray findings with semi-quantitative
RT-PCR
To validate microarray results, we arbitrarily selected 15
differentially expressed genes in 20-weeks remnant WT
kidneys and quantified their expression by semi-quantitative
real time-polymerase chain reaction (sqRT-PCR) in the
available WT remnant and WT control kidney samples.
Additionally, we validated a number of genes by RT-PCR,
found to be differentially expressed in 20-week remnant
kidneys of SNX-B1R-KO or SNX-B2R-KO mice compared
with SNX-WT control animals. All sqRT-PCR analyses were
performed in samples previously used for the microarray
experiments. Table 5 summarizes the gene expression
measurements of all validated genes. We found that both
methods (microarray analysis and sqRT-PCR) detected
similar patterns for the upregulated and downregulated
genes selected for validation.
Histological analysis of remnant kidney tissues reveals
higher levels of renal fibrosis in the B2R-KO SNX mice
In remnant kidneys of the WT and kinin receptor-KO
animals, examination (Masson’s trichrome staining) of
kidney tissue revealed classical alterations such as glomerular
hypercellularity and mild glomerular sclerosis (Figure 6). We
have also noticed some tubular dilation and scarce areas with
tubulointerstitial fibrosis. a-Smooth muscle actin staining
was only observed in the intrarenal arteries and macrophage
infiltration was mainly located around the gomeruli
(not shown).
Whereas there was no difference in the gomerular
diameter between the WT, B1R- and B2R-KO kidney mice
under physiological conditions (respectively, 70.5575.2,
68.0977.78, and 66.1376.27 mm), we found that the
glomerular diameter was significantly higher in the SNX-
B2R-KO kidney mice compared with those observed in the
SNX-WT and B1R-KO remnant kidney (Figure 6a–c). More-
over, the level of tubulointerstitial fibrosis was significantly
higher in the B2R-KO SNX mice (4.870.7%) compared with
that in the SNX-WT mice (2.570.4%) (Figure 6d–f).
Although not significant, a tendency to a lower macrophage
infiltrate was observed in the B1R-KO remnant kidneys (not
shown).
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Figure 5 | Hierarchical clustering of 20-week remnant kidneys
that discriminates between SNX-B1R-KO and SNX-B2R-KO kidney
samples. A subset of candidate genes were initially obtained by
filtering on signal intensity (twofold), retaining 306 genes. One-way
analysis of variance parametric test (Welch t-test; variances not
assumed equal; Pp0.05) further selected 65 genes. Clustering
analysis based on the 65 gene list was performed using the standard
Condition Tree algorithm provided in GeneSpring. The mean appears
grey, whereas red signifies upregulation, and green signifies
downregulation (see legend bar). B1R SNX kidney samples are
indicated in grey; B2R SNX kidney samples are indicated in blue.
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DISCUSSION
Molecular mechanisms of advanced renal disease
Functional classification of differentially expressed genes in
20-week remnant WT kidneys revealed marked overexpres-
sion of genes involved in inflammation/immune response,
fibrosis, cell adhesion, apoptosis, and altered metabolism and
transport (Table 1A). A consistent finding of our study was
the dramatic upregulation of numerous members of the CYP
gene family (Table 1A and Table S1). The induction of
different CYP genes could lead to altered metabolism,
inflammation, and oxidative stress in renal tissue.13 However,
our microarray data show predominant upregulation of CYP
members from the 2b and the 2c gene subfamilies that are
known to be involved in vasodilation and as anti-inflamma-
tory and angiogenic mediators,14,15 which could lead to
possible compensatory (protective) effects during advanced
renal disease.
The observed strong upregulation of several oxidases
(Maob, Uox, Hao3, Cp, Hao1) probably contributes to
oxidative stress and renal damage in the 20-week remnant
kidneys. In contrast, we have also monitored significant
overexpression of different genes with demonstrated anti-
inflammatory and antioxidant effects in renal pathology.
These genes comprise transferrin (Trf) and its transferrin
receptor 2 (Trfr2),16 uncoupling protein 1 (Ucp1),17 as well
as different members (Gsta1, Gsta2, Gsta3) of the GST gene
family18 and the aldo-keto reductase (AKR) gene family
(Akr1c20, Akr1c6, Akr1c12, Cbr1).19 Both GST and UCP
genes were also found to be strongly upregulated in rat
kidneys following ethylene glycol-induced urolithiasis20 and
upon renal ischemia–reperfusion (I/R) injury in mice and
rats,21 as Gsta1 was also shown to be overexpressed in kidneys
of sickle-cell transgenic mice.22
Another important gene group that showed marked
induction in 20-week remnant kidneys included transcripts
of the apolipoprotein family encoding for molecules involved
in lipid metabolism and transport. Disturbances in lipid
metabolism are often observed in patients with chronic renal
failure,23 as the negative impact of proteinuria on ESRD
progression could be mediated in part through increased
filtration of lipoproteins.24
Transcripts belonging to the serine proteinase inhibitors
(serpins) gene family were also consistently overexpressed in
20-week remnant kidneys. Almost no data are available for
implications of serpins in renal pathology. However, given
their recently proposed role in regulating renal inflammation
Table 4 | Genetic networks in remnant kidneys of the kinin receptors-KO mice
Network Genes in ingenuity networksa Scoreb Focus genesc Functions
(A) Networks in remnant kidneys of SNX-B1R-KO mice (upregulated genes)
1 AGXT, APOA1, APOC1, APOC3, COX8B, CYP3A2, F2, F10*, FGB, ITGA6, MUP4, PLG, PON1,
SERPINC1, SERPIND1, TFR2
29 16 Lipid metabolism,
molecular transport
2 AHSG, ARG1*, C5, CIDEA, DF*, ELOVL6, HP, HPX, MBL2, MYO5A, ORM1, SAA4, SERPINAC3
(Kalbp)
22 13 Development, lipid
metabolism
3 AMBP, ARG1*, BAAT, CYP3A7, DF*, F10*, HDC, HLA-B, IGJ, MGC27165, ORM2, SERPINA3K,
UCP1
22 13 Cellular growth and
proliferation
(B) Networks in remnant kidneys of SNX-B1R-KO mice (downregulated genes)
1 BCL2L2, BMF, BRCA2, CD36*, HDAC2, ITGB1, MEOX2, NFKBIZ, PLF2, PTPN4, SDHA,
SH3GLB1, TM4SF8, TSC22D1
24 14 Gene expression,
cellular movement
2 ABHD5, CDH17, CYP4B1, G0S2, MPRA, POLR3E, RAP1B, SFRS1, SLAMF6, SLC20A1,
SLC30A1, SLCO1A1, SNX6, UGT2B7
24 14 Cellular growth and
proliferation
3 AKR1C2, BRF1, CD36*, CENPB, CES1, DARS, EIF5A, ENPEP, HSPA8, LACTB, NBR1, TP53BP2,
TSC22D3
21 13 Gene expression
(C) Networks in remnant kidneys of SNX-B2R-KO mice (upregulated genes)
1 ANTXR1, APCS, ARG1*, CD163, CPB2, DHCR7, FGG*, HP, ITIH3, LCAT, LRG1, MAT1A,
ORM1*, SAA2, SERPINA3
27 15 Immune response,
cellular growth and
proliferation
2 ALAD, CD3D, CPS1, CYP2F1, EDN1, FASN, GSTM2, HAND1, HAO1, HCK, HPX, ORM1, SOX18 22 13 Lipid metabolism,
molecular transport
3 ARG1*, CDGAP, CYP3A7, FGA, FGB, FGG*, FKBP5, GSTM1, ORM2, PC4, PSMD11, RPS6KA1 20 12 Cell signaling
(D) Networks in remnant kidneys of SNX-B2R-KO mice (downregulated genes)
1 ABCD3, CAMP, CCL27, CTSC, ERCC2, GHSR, IGH1A, PHIP, PLEC1, PRKACA, PRKCI, SP100 23 12 Immune response,
cellular growth and
proliferation
2 CAST (ERC2), KIF11, NRG3, NT5E, PTN, RASSF4, SYCP3, TFRC, ZBTB33 16 9 Lipid metabolism,
molecular transport
B1R, kinin receptor, which is overexpressed in pathological states; B2R, kinin receptor, which is constitutively expressed; KO, knockout; SNX, subtotal or 5/6 nephrectomy.
aGenes marked with asterisk are present in more than one network. Bold genes are present in networks identified by both experimental conditions (including B1R-KO and
B2R-KO mice).
bThe table displays only networks with significant scores (score 43 is considered as significant).
cOnly genes identified by microarray analysis (focus genes) that are differentially expressed (X2-fold) are listed.
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and tissue repair during kidney regeneration,25 one can
consider their overexpression in the remnant kidneys as a
possible compensatory mechanism during disease progres-
sion. Interestingly, a number of serpin genes were also found
to be strongly upregulated in mouse kidneys following renal
I/R, and a role for serpins in conferring protection from I/R
injury was proposed.21
Genes encoding for enzymes of the urea cycle, including
both arginase enzymes (Arg1 and Arg2), were also con-
sistently induced in remnant kidneys (Table 1A). It was
previously shown that Arg2 is present in the proximal tubules
and is implicated in tubular repair.26 Comparable compen-
satory changes in enzymes of the urea cycle were also
monitored in hypertrophied mouse kidneys after streptozo-
tocin-induced diabetes,27 renal I/R,22 unilateral nephrect-
omy,27 and in kidneys of sickle-cell transgenic mouse.22
Transcripts encoding for different MUPs were highly
overexpressed in 20-week remnant kidneys. MUPs are
involved in pheromone transport, detoxification, inflamma-
tory responses, and animal behavior.28 MUP expression was
reported to be upregulated by androgen stimulation in the
mouse kidney.29 Although the entire spectrum of biological
Table 5 | sqRT-PCR validation of microarray data
GenBank No. Common name
Fold expression (SNX-WT/WT-C)
Microarray sqRT-PCRa
(A) Comparison of the qualitative results obtained by microarray analysis and conventional method (sqRT-PCR) in kidney tissues from SNX-WT mice
versus WT control mice
NM_009654 Albumin 1 (Alb1) +267.50 +55.29
NM_031188 Major urinary protein 1 (Mup1) +94.96 +10.30
NM_011548 Serpin clade A, 3K (Serpina3k) +94.27 +43.60
NM_017399 Fatty acid-binding protein 1 (Fabp1) +64.35 +21.46
AK008765 Retinol-binding protein 4 (Rbp4) +63.18 +9.73
NM_009692 Apolipoprotein A-1 (Apoa1) +59.52 +23.12
NM_080852 Solute carrier family 7, member 12 (Slc7a12) +52.90 +10.15
NM_023125 Kininogen 1 (Kng1) +52.84 +4.87
NM_177380 Cytochrome P450 3a44 (Cyp3a44) +34.86 +37.59
NM_011134 Paraoxonase 1 (Pon1) +36.51 +7.83
NM_133862 Fibrinogen, gamma (Fgg) +24.68 +5.75
NM_007576 Complement 4 binding protein (C4bp) +22.67 +17.89
NM_023114 Apolipoprotein C-III (Apoc3) +19.53 +8.04
NM_019946 Microsomal glutathione S-transferase 1 (Mgst1) +8.94 +3.07
NM_013797 Solute carrier, member 1a1 (Slco1a1) 55.25 26.01
Fold expression (SNX-B1R-KO/SNX-WT)
GenBank No. Common name Microarray sqRT-PCRa
(B) Comparison of the qualitative results obtained by microarray analysis and conventional method (RT-PCR) in remnant kidneys from either SNX-B1R-KO
or SNX-B2R-KO mice versus SNX-WT mice
NM_134066 Aldo-keto reductase 1, member c18 (Akr1c18) +10.47 +2.04
NM_023114 Apolipoprotein C-III (Apoc3) +5.17 +1.36
BY426609 Immunoglobulin J558, heavy chain (IgJ558) +4.52 +1.60
AK011118 Fibrinogen, B beta (Fbb) +4.13 +6.05
NM_007443 Alpha 1 microglobulin (bikunin) +4.09 +2.88
Fold expression (SNX-B2R-KO/SNX-WT)
GenBank No. Common name Microarray sqRT-PCR
AK031900 RIKEN cDNA library, clone: 6330442E02 +8.39 +2.34
NM_017371 Hemopexin (Hpxn) +7.03 +3.89
NM_009252 Serpin clade A, 3N (Serpina3n) +4.11 +3.21
AK007175 RIKEN cDNA library, clone: 1700112E06 +3.46 +2.61
BY426609 Immunoglobulin J558, heavy chain (IgJ558) +3.24 +2.57
AK011118 Fibrinogen B-beta (Fgb) +3.11 +3.80
NM_011016 Orosomucoid 2 (Orm2) +2.91 +4.17
NM_010196 Fibrinogen alpha (Fga) +2.66 +2.01
NM_133862 Fibrinogen gamma (Fgg) +2.62 +1.94
NM_010104 Endothelin 1 (Edn1) +2.04 +1.75
NM_031192 Renin 1 (Ren1) +2.03 +1.84
NM_172841 Solute carrier, member 5A1 (Slco5a1) 15.58 12.30
NM_008973 Pleiotrophin (Ptn) 2.95 1.72
B1R, kinin receptor, which is overexpressed in pathological states B2R, kinin receptor, which is constitutively expressed; C, control; KO, knockout; RT-PCR, real time-polymerase
chain reaction; SNX, sqRT-PCR, semi-quantitative real time-polymerase chain reaction; WT, wild-type.
aThe sqRT-PCR data represent medium values of triplicate RT-PCR experiments, as the specific gene expression was compared at random between three separate pairs of
experimental animals.
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functions of MUPs are still unknown, the upregulated
expression of androgen-regulated genes suggests that MUPs
may mediate the androgen-dependent tissue injury in
nephrectomized kidneys and may be additionally involved
in the disruption of protein secretion and transport in ESRD.
Interestingly, similar overexpression of MUP genes was
demonstrated in 2-week remnant mouse kidneys,30 and in
a mouse model of autosomal recessive polycystic kidney
disease.31
We want to especially point out several genes relevant to
kidney pathology, which displayed strong upregulation in 20-
week remnant kidneys. These include Alb1, Ahsg, Crp, Rbp4
and Kng1. Among these, Alb1, Ahsg, Rbp4 and Crp represent
proven protein markers for clinical outcome in ESRD
patients.32
As expected, remnant kidneys displayed strong down-
regulation of genes implicated in cell growth and metabolism,
including genes involved in lipid (fatty acid) and protein
biosynthesis (Table 1B and Table S2). Indeed, increased
protein catabolism and decreased lipid and protein synthesis
are common phenomena in renal failure.33 Lower expression
rates were also found for several cell adhesion genes (Pcdhb9,
Pcdh8, Itga2b, Lama1), which probably contribute to ESRD
progression, as loss of epithelial cell adhesion represents the
initial step to epithelial-to-mesenchymal transition, a phe-
notypic conversion that is fundamentally linked to the
pathogenesis of renal interstitial fibrosis.34
Several genes relevant to renal pathology were down-
regulated in the 20-week remnant kidneys. These include
several hemoglobins (Hba-a, Hb-b, Hb-b-b1), the natriuretic
peptide precursor type B gene (Nppb), the polycystic kidney
disease 2 (Pkd2) and ACE1. The downregulation of the
hemoglobin genes probably contributes to anemia, which is a
common complication of ESRD.35 Although the roles of
Nppb and Pkd2 in chronic renal failure are still not well
defined, a suppression of ACE1 gene expression could
obviously mediate protective effects against ESRD progres-
sion in remnant kidneys.
Network analysis identified several signaling pathways
(Fos, Thr, Fn1, Fgf2, Crp, Plg, Igf1, and Hnf4A signaling) that
displayed maximal transcriptional activity in 20-week
remnant kidneys (Figure 2). Indeed, FOS induction has been
previously associated with activation of mechanisms that
induce and amplify the damage during progression of renal
disease.36 As seen in Figure 2, the Thr, Fn1, Crp, and Plg
signaling pathways are highly interactive as these molecules
have been associated with abnormalities of coagulation
(vascular thrombosis), increased fibrosis, and inflammation
in ESRD patients.37 The IGF signaling is suggested to
influence the pathogenesis of renal diseases,38 and a link
was shown between inflammation and Igf1 activity, which is
decreased in inflamed individuals.39 Thus, our data are
suggestive for protective effects of IGFs (Igf1, Igf2, IgfB)
overexpression in advanced renal failure. Similar upregula-
tion of different members of the IGF gene family was also
observed in other animal models of renal pathology,
including renal I/R21 and spontaneous congenital unilateral
obstructive uropathy.40
Additionally, we have identified a novel pathway asso-
ciated with the Hnf4A signaling that could be potentially
implicated in mechanisms of chronic renal disease. Hnf4A
belongs to the steroid/thyroid hormone receptor superfamily
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Figure 6 | Histological analysis of remnant kidney tissues. Histological appearance of glomeruli in (a) SNX-WT mice, (b) SNX-B1R-KO
mice, and (c) SNX-B2R-KO mice. Representative photographs of Masson trichrome-stained renal sections of (d) 20-week remnant kidney
tissues of SNX-WT mice, (e) SNX-B1R-KO mice, and (f) SNX-B2R-KO mice. Arrows indicated accumulation of interstitial collagen (blue). Bars
represent the quantitative analysis where data are expressed as the mean7s.d. *Po0.05 versus SNX-WT. Original magnification  200.
Histological analyses were performed on five mice/group.
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of transcription factors and is involved in the regulation of
serum lipid and glucose levels.41 Mutations in this gene are
responsible for maturity onset diabetes of the young, a
monogenic dominant inherited form of diabetes mellitus
characterized by defective insulin secretion of the pancreatic
beta-cells;42 however, there are no literature data available
that directly link Hnf4a expression and activity to renal
physiology and/or pathology, The Hnf4a signaling pathway
(Figure 3) includes genes mainly involved in fatty acid and
glycerophospholipid metabolism and transport (Apoc1,
Apoe, Apo2, Apo1, Apoc3, Lcat, Slc27a2, and Pyg1), as well
as different members of the complement and coagulation
cascade (C4a, Tdo2, Fga, Fgb, C8g, C9, and Clu). Recent data
indicate that Hnf4a coordinates the developmental expres-
sion of an extensive array of cell junction and adhesion
proteins in the liver.43 Thus, the detailed mechanisms for
implication of Hnf4a signaling in renal pathology remain to
be elucidated.
Different animal models of renal pathology have been
used to study disease mechanisms applying the microarray
technology.20–22,40,44–46 However to our knowledge, the
present work represents the first effort to define global
changes in renal gene expression during nephropathy
progression in SNX animal models using high-density
microarrays. As our microarray experiments were performed
in whole kidney tissues, future cellular localization experi-
ments will be needed in remnant kidney tissues for better
selection and characterization of potential ESRD biomarkers.
Role of kinin receptors in ESRD
A large body of evidence supports a role of the endogenous
kallikrein–kinin system on various aspects of renal function
and pathology.8 We have observed different differential gene
expression patterns in B1R-KO and B2R-KO 20-week remnant
kidneys that are supportive for distinct mechanisms of
implications for each kinin receptor subtype in chronic renal
disease. According to our data, kinin B1R ablation potentiates
some gene expression alterations observed in the 20-week
WT remnant model although less marked than invalidation
of the B2R. This correlated with the absence of effect on the
level of fibrosis (Figure 6). However, the role of the B1R
might be more important in the early stages of chronic renal
disease where the inflammatory component is more ex-
acerbated.47
The effect of the B2R gene knockout in 20-week remnant
kidneys seems to be more profound, as B2R-KO 20-week
remnant kidneys display strong overexpression for a number
of mediators of inflammation, immune, and acute phase
response (Fga, Fgb, Fgg, Hp, Hpxn, IgJ588, Orm1, Orm2,
SerpinA3N, Cnlfsf2b). Additionally, some genes with poten-
tial importance in renal fibrosis, including haptoglobin
(Hp),48 serum amyloid A2 (Saa2),49 Fga, Fgb and Fgg,50
Edn1,51 and Ren152 were overexpressed in remnant kidneys
of SNXB2R-KO mice. Overall this suggests that the B2R is an
endogenous protector in this chronic renal disease model.
This is also confirmed by the significantly increased
glomerular diameter and level of renal fibrosis in the SNX-
B2R-KO mice, compared with SNX-WT and SNX-B1R-KO
mice (Figure 6). Our data support previous findings for the
endogenous protective effect of the B2R against renal fibrosis,
inflammation, and glomerular hypertrophy.53–55
In conclusion, we used the remnant kidney model to
define global changes in renal gene expression during
nephropathy progression in 20-week SNX animals, to
understand better the molecular mechanisms of advanced
renal disease. We discussed several gene groups and
corresponding signaling pathways that were differentially
expressed in 20-week remnant kidneys and that are
functionally related to vascular damage, inflammation,
oxidative stress, altered metabolism and transport, fibrosis,
and proteinuria, events seen in the evolution of ESRD.
A potentially new ESRD pathway was identified, linked to
Hnf4a signaling. We also observed altered expression of genes
linked with protective and compensatory mechanisms to
disease progression. Our data also suggest for a protective
role of the kinin B2R subtype in chronic renal disease and its
progression toward ESRD. However, this needs to be further
confirmed by performing chronic blockade of kinin receptors
in SNX-WT mice with specific antagonists.
Results described in this study underscore the potential of
the microarray technology for unraveling the complex
mechanisms of advanced renal failure. In perspective, we intend
to perform similar gene expression analyses using our remnant
WT and kinin receptors KO models in earlier stages following
SNX, to better understand the complex molecular mechanisms
involved in the kinetics of progression to ESRD and the
involvement of kallikrein–kinin system in renal pathology.
MATERIALS AND METHODS
Animals
B1R-KO and B2R-KO mice were generated by gene targeting and
homologous recombination.56,57 All experiments were performed
with 12–16-week-old male mice from breedings that have been
previously backcrossed for 10 generations against a C57Bl/6J strain
to homogenize the genetic background of our B1R-KO and B2R-KO
mice. Initial microsatellite analysis showed that our B2R-KO mice
are genetically comparable with C57Bl/6j mice.58 Similar results
were obtained for the B1R-KO mice. Accordingly, C57BL/6J male
mice (The Jackson Laboratories, Bar Harbor, ME, USA) were used
as WT controls. The mice were housed in the animal quarters with a
12-h light/dark cycle and maintained on a standard chow diet
(Purina Rodent Chow 5002) and distilled water ad libitum. This
study was conducted in accordance with the guidelines for the Care
and Use of Animals approved by the Animal Protection Committee
of Laval University.
Subtotal (5/6) nephrectomy
Three groups of mice (B1R-KO, B2R-KO and WT; n¼ 6–8) were
submitted to subtotal nephrectomy. The procedure was performed
in anesthetized mice (pentobarbital 50 mg/kg intraperitoneally). The
left kidney was exposed via a flank incision and both poles were
excised (approximately two-thirds of the kidney), leaving a small
amount of renal tissue around the left ureter and hilar vessels. Blood
loss was minimized by the application of gelatin sponges. After a
452 Kidney International (2007) 72, 442–454
o r i g i n a l a r t i c l e JP Schanstra et al.: Gene expression profiling in the remnant kidney model
7-day recovery period, again under anesthesia, the right kidney was
removed, leaving 20–25% of the total renal mass. Renal function was
allowed to stabilize for 1 week before further treatments. Sham-
operated B1R-KO, B2R-KO, and WT animals (n¼ 4–5) that have only
underwent laparotomy were used as controls. The animals were
killed 20 weeks after the last surgical intervention. A part of the
remnant or the control kidney was snap-frozen and stored at 801C
for RNA extraction and microarray analyses, whereas the remaining
part was processed for histological analyses. Several biochemical
analyses (serum creatinine, urine creatinine, and proteinuria
measurements) were performed on urine and blood samples
collected before killing of the experimental animals (n¼ 4/group).
In unanesthetized mice measurements of binding potential were
performed before killing by the tail-cuff plethysmography method,
as described previously.58 Unpaired t-test was used to analyze these
data. Po0.05 were considered statistically significant.
Gene expression profiling and data analysis
These experiments included 3–6 pairs of mice per study group. All
microarray experiments were performed in multiple replicates. Gene
expression analysis was carried out as described previously.9,59
Labeled cRNAs were applied to the Agilent 44K Mouse Whole
Genome Oligonucleotide Microarray (containing 41 534 genes).
Cyanine-labeled cRNA (0.75 mg) from one remnant WT kidney
(SNX-WT) sample was mixed with the same amount of reverse-
color cyanine-labeled cDNA from one WT control (WT-C) kidney
sample. Alternatively, cyanine-labeled cRNA (0.75 mg) from one
B1R-KO or B2R-KO remnant kidney (SNX-B1R-KO or SNX-B2R-
KO) sample was mixed with the same amount of reverse-color
cyanine-labeled cDNA from one WT remnant kidney (SNX-WT)
sample. Array hybridization, washing, scanning, data extraction, and
analyses were performed as described previously.9,59 Network
analysis of the microarray data was completed using the Ingenuity
Pathway Analysis (IPA) software (see http://www.Ingenuity.com).
Semi-quantitative duplex RT-PCR
Validation of microarray data was performed for selected differen-
tially expressed genes by sqRT-PCR as described previously.9 The
glyceraldehyde-3-phosphate dehydrogenase (Gapdh) gene was used
as internal standard. Primers were designed for these loci with the
sequences freely available from the Entrez Nucleotide database and
the Primer3 algorithm for primer design (http://www-genome.
wi.mit.edu/cgi-bin/primer/primer3_www.cgi).
Immunohistomorphometric analyses
The development of histological lesions in the renal tissue of the
SNX animals and protein expression of different markers was
examined using a combination of immunohistochemistry and
histomorphometric analyses, as shown previously.54 The diameter
of glomeruli, spanning from the vascular pole to the opposite
Bowman’s capsule, was measured by using the Explora Nova Mosaı¨c
software (Explora Nova, La Rochelle, France). Statistical analyses
were performed using the Graphpad Prism software. Unpaired t-test
was performed for comparison between the different groups.
Po0.05 were considered statistically significant.
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